中医穴位贴敷治疗腹泻回顾性队列研究OA
Effect of Chinese Medicine Acupoint Application for Diarrhea:A Retrospective Cohort Study
目的 探讨中医穴位贴敷治疗腹泻的有效性及有效人群特征、贴敷处方特点.方法 采用回顾性队列研究方法,基于互联网诊疗平台2022年5月—2023年5月的腹泻病例资料,按是否使用穴位贴敷治疗分为暴露组(贴敷组)和非暴露组(非贴敷组).采用倾向性评分匹配(PSM)调整年龄、性别等混杂因素,以治疗1、2、3天腹泻消失率为疗效观察指标,采用多因素回归分析评估疗效,并利用关联规则分析有效人群特征及处方规律.结果 PSM后贴敷组3 012例,非贴敷组1 593例,贴敷组治疗1、2 天腹泻消失率优于非贴敷组(P<0.001),OR 分别为 1.933(1.623~2.304)、1.507(1.321~1.718),中位消失时间更短(2.333 vs.3.042天,x2=43.874,P<0.001).多因素回归分析显示,治疗1、2、3天腹泻消失率贴敷组均优于非贴敷组(P<0.001),OR分别为2.028(95%CI:1.639~2.510)、1.744(95%CI:1.480~2.055)及1.395(95%CI:1.197~1.627).分层分析与交互作用检验显示,是否使用抗生素以及其他腹泻药物两个因素与暴露因素间有明显的交互作用(P<0.001),仅在不合并使用抗生素或其他腹泻药物时,贴敷组疗效优于非贴敷组(P<0.001).使用中医穴位贴敷治疗的有效病例10 803例,其中3岁以下婴幼儿占比最高,常用的贴敷穴位包括神阙、中脘、大椎、涌泉等,其中最常联用的穴位是中脘和神阙,支持度为58.42%;常用的贴敷药物包括黄连、芒硝、吴茱萸、藿香等,其中黄连最常贴敷于神阙穴,支持度为33.33%.结论 中医穴位贴敷治疗腹泻有效,且单独应用相较联合用药可能具有一定优势,神阙与黄连分别为最常用的穴位和药物.
Objective To explore the effectiveness of Chinese medicine(CM)acupoint application therapy in the treatment of diarrhea,as well as the characteristics of responsive patient populations and prescription patterns.Methods A retrospective cohort study was conducted utilizing data from diarrhea cases recorded on an online healthcare platform between May 2022 and May 2023.Patients were categorized into an exposure group(acupoint application group)and a non-exposure group(non-acupoint application group).Propensity score matching(PSM)was employed to adjust for confounding factors such as age and sex.Primary outcomes were diarrhea resolution rates on days 1,2,and 3.Multivariate logistic regression was used to assess treatment effectiveness.Association rule mining was performed to analyze the characteristics of effective subpopulations and commonly used prescriptions.Results Following PSM,the acupoint application group(3 012 cases)demonstrated significantly higher diarrhea resolution rates on days 1 and 2 compared to the non-application group(1 593 cases,P<0.001),with odds ratios(OR)of 1.933(95%CI:1.623~2.304)and 1.507(95%CI:1.321~1.718),respectively.The median time to resolution was shorter in the treatment group(2.333 vs.3.042 days,x2=43.874,P<0.001).Multivariate regression further confirmed higher resolution rates in the treatment group on days 1,2,and 3(all P<0.001),with OR of 2.028(95%CI:1.639~2.510),1.744(95%CI:1.480~2.055),and 1.395(95%CI:1.197~1.627),respectively.Interaction analysis revealed significant effect modification by the use of antibiotics or other antidiarrheal agents(P<0.001);the beneficial effects of acupoint application were evident only in patients not receiving these concurrent treatments.Among the 10 803 cases with effective responses to acupoint therapy,children under 3 years of age constituted the largest subgroup.The most frequently applied acupoints were Shenque(CV8),Zhongwan(CV12),Dazhui(GV14),and Yongquan(KI1),with the most common combination being Zhongwan(CV12)and Shenque(CV8)(support:58.42%).The most commonly used herbal ingredients included Coptis chinensis,Natrii Sulfas,Evodia rutaecarpa,and Agastache rugosa,with Coptis chinensis most frequently applied to the Shenque(CV8)(support:33.33%).Conclusions CM acupoint application appears effective for the treatment of diarrhea.Monotherapy showed certain advantages than combination therapy,Shenque(CV8)and Coptis chinensis were the most frequently used acupoint and herbal agent,respectively.
李庆娜;牛粉玲;雷激光;李清霄;苏磊;陈洋;石玉来;谢继瑞;朱明波;靳韬;陆芳;蒋艳文;高蕊;主佳旭;郭曼萍;王一名;栗蕊;陈海涛;郭建;甘文帆
中国中医科学院西苑医院临床药理研究所(北京 100091)国家药品监督管理局中药临床研究与评价重点实验室(北京 100091)国家中医心血管病临床医学研究中心(北京 100091)河南省濮阳市九和中医门诊部(河南 457005)春播运营平台豫北省区学术部(郑州 450000)春播运营平台豫北省区学术部(郑州 450000)春播运营平台湖南省区学术部(长沙 410000)湖南省株洲市天元彭晚姣诊所(湖南 412007)春播运营平台皖北省区学术部(合肥 230000)春播运营平台皖南省区学术部(安徽 246000)北京华康嘉合科技有限公司(北京 100079)北京华康嘉合科技有限公司(北京 100079)中国中医科学院西苑医院临床药理研究所(北京 100091)国家药品监督管理局中药临床研究与评价重点实验室(北京 100091)国家中医心血管病临床医学研究中心(北京 100091)国家中医心血管病临床医学研究中心(北京 100091)中国中医科学院西苑医院儿科(北京 100091)中国中医科学院西苑医院临床药理研究所(北京 100091)国家药品监督管理局中药临床研究与评价重点实验室(北京 100091)国家中医心血管病临床医学研究中心(北京 100091)
腹泻穴位贴敷中医药有效性贴敷处方回顾性队列研究真实世界研究
diarrheaacupoint applicationChinese medicinetreatment effectivenessprescription patternretrospective cohort studyreal-world study
《中国中西医结合杂志》 2026 (1)
25-32,8
北京市海淀区卫生健康发展科研培育计划(No.HP2023-50-504004)中国中医科学院科技创新工程项目(No.CI2021A04701)中国中医科学院西苑医院中医药临床科研一体化平台建设专项(No.XYZX0404-06)河南省中医药科学研究专项课题(No.2022JDZX120)
评论